Consolidated Condensed Interim Statement of Loss and Comprehensive Loss (Unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Dec. 31, 2016 |
Dec. 31, 2015 |
Dec. 31, 2016 |
Dec. 31, 2015 |
|
Expenses | ||||
Research and development | $ 1,120,910 | $ 789,187 | $ 1,853,639 | $ 1,393,032 |
General and administrative | 571,286 | 890,672 | 1,887,925 | 1,364,697 |
Operating expenses | 1,692,196 | 1,679,859 | 3,741,564 | 2,757,729 |
Other loss (income) | ||||
Change in fair value of stock option and derivative liabilities | (361,668) | 680,188 | (135,980) | 1,219,634 |
Change in fair value of derivative liability due to change in warrant terms | 242,400 | 263,965 | ||
Foreign exchange | (8,495) | 44,253 | 6,829 | 26,780 |
Interest income | (60) | (10) | (101) | (30) |
Other (income) loss | (370,223) | 966,831 | (129,252) | 1,510,349 |
Net and comprehensive loss for the period | 1,321,973 | 2,646,690 | 3,612,312 | 4,268,078 |
Computation of basic loss per share | ||||
Net and comprehensive loss for the period | (1,321,973) | (2,646,690) | (3,612,312) | (4,268,078) |
Series B Preferred stock dividend | 159,756 | 467,054 | ||
Net and comprehensive loss available to common stockholders | $ (1,481,729) | $ (2,646,690) | $ (4,079,366) | $ (4,268,078) |
Basic and fully diluted loss per share | $ 0.13 | $ 0.24 | $ 0.36 | $ 0.40 |
Basic weighted average number of shares | 11,424,485 | 10,994,879 | 11,363,237 | 10,808,660 |
X | ||||||||||
- Definition Change in fair value of derivative liability due to change in warrant termsChange in fair value of derivative liability due to change in warrant terms. No definition available.
|
X | ||||||||||
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. No definition available.
|
X | ||||||||||
- Definition Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Amount of interest income earned from interest bearing assets classified as other. No definition available.
|
X | ||||||||||
- Definition Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders. No definition available.
|
X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|